4//SEC Filing
Beetham Thomas W. 4
Accession 0000950170-24-110485
CIK 0001590750other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 7:12 PM ET
Size
16.3 KB
Accession
0000950170-24-110485
Insider Transaction Report
Form 4
Beetham Thomas W.
Chief Operating Officer
Transactions
- Purchase
Common Stock
2024-09-27$23.41/sh+5,000$117,050→ 6,000 total
Footnotes (1)
- [F1]Includes 1,000 shares acquired under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan (the "ESPP") on September 19, 2024 in transactions that were exempt under Rule 16b-3(c).
Documents
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001741382
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 7:12 PM ET
- Size
- 16.3 KB